<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: Symptomatic <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> is a major complication in patients with <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> (SAH) </plain></SENT>
<SENT sid="1" pm="."><plain>Symptomatic <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> has been reported to be related to the patient's blood volume which is influenced by cerebral <z:hpo ids='HP_0000127'>salt wasting</z:hpo> syndrome (CSWS) </plain></SENT>
<SENT sid="2" pm="."><plain>We undertook a prospective study to assess whether the <z:hpo ids='HP_0003674'>onset</z:hpo> of symptomatic <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> was predictable or not, by observing the phenomena of CSWS (<z:mp ids='MP_0006316'>natriuresis</z:mp> and osmotic <z:mp ids='MP_0001762'>diuresis</z:mp>) </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Sixty-seven consecutive aneurysmal SAH patients were analysed </plain></SENT>
<SENT sid="4" pm="."><plain>After surgery, <z:hpo ids='HP_0000001'>all</z:hpo> patients underwent hypervolemic therapy in order to keep central venous pressure (CVP) within 8-12 cmH(2)O, serum <z:chebi fb="199" ids="26708">sodium</z:chebi> level above 140 mEq/l and a positive water balance </plain></SENT>
<SENT sid="5" pm="."><plain>Patients were classified into two groups: those without symptomatic <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> (n=55) and those with symptomatic <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> (n=12) </plain></SENT>
<SENT sid="6" pm="."><plain>To estimate <z:mp ids='MP_0006316'>natriuresis</z:mp> and osmotic <z:mp ids='MP_0001762'>diuresis</z:mp>, <z:chebi fb="199" ids="26708">sodium</z:chebi> in/out, water in/out, CVP and other parameters were measured and compared between the two groups </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: One day before symptomatic <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e>, three factors reached statistical difference in the group that experienced symptomatic <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e>: <z:chebi fb="199" ids="26708">sodium</z:chebi> balance, urine volume and water balance </plain></SENT>
<SENT sid="8" pm="."><plain>On the day of symptomatic <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e>, two factors reached statistical difference: <z:chebi fb="199" ids="26708">sodium</z:chebi> excretion and urine volume </plain></SENT>
<SENT sid="9" pm="."><plain>No factor was significantly different 2 days before symptomatic <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>DISCUSSION: Symptomatic <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> has a strong relationship with CSWS </plain></SENT>
<SENT sid="11" pm="."><plain>Negative <z:chebi fb="199" ids="26708">sodium</z:chebi> and water balance and increased urine volume indicate a predictor of symptomatic <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>To predict symptomatic <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e>, strict observations are required, because CSWS and symptomatic <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> which follows, develop rapidly </plain></SENT>
</text></document>